Type I interferons triggered through the Toll-like receptor 3-TRIF pathway control coxsackievirus A16 infection in young mice

Journal of Virology

Volumn 89, Issue 21, 2015, Pages 10860-10867

  Yang, Juhao ^a   Yang, Chunfu ^a   Guo, Nining ^a   Zhu, Kai ^a   Luo, Kaiming ^a   Zhang, Na ^a   Zhao, Hui ^b   Cui, Ying ^a   Chen, Lei ^c,d   Wang, Hongyang ^c,d   Gu, Jun ^e   Ge, Baoxue ^f   Qin, Cheng Feng ^b   Leng, Qibin ^a  

^a INSTITUTE PASTEUR OF SHANGHAI   (China)

^b BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

^c SECOND MILITARY MEDICAL UNIVERSITY   (China)

^d National Scientific Centre for Liver Cancer   (China)

^e PEKING UNIVERSITY   (China)

^f TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; GAMMA INTERFERON; INTERFERON; INTERFERON RECEPTOR; PATTERN RECOGNITION RECEPTOR; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR ADAPTOR MOLECULE 1; PRIMER DNA; TICAM-1 PROTEIN, MOUSE; VESICULAR TRANSPORT ADAPTOR PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; COXSACKIE VIRUS INFECTION; COXSACKIEVIRUS A16; DISEASE SEVERITY; IMMUNE DEFICIENCY; INFECTION CONTROL; MORTALITY; MOUSE; NATURAL KILLER T CELL; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; SURVIVAL; TYPE I INTERFERON RECEPTOR DEFICIENCY; VIRUS IMMUNITY; VIRUS REPLICATION; ANIMAL; C57BL MOUSE; COXSACKIEVIRUS INFECTIONS; DEFICIENCY; DENDRITIC CELL; FLOW CYTOMETRY; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; METABOLISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

ADAPTOR PROTEINS, VESICULAR TRANSPORT; ANIMALS; COXSACKIEVIRUS INFECTIONS; DENDRITIC CELLS; DNA PRIMERS; FLOW CYTOMETRY; INTERFERON TYPE I; INTERFERON-BETA; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 3;

EID: 84945206710     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01627-15     Document Type: Article

References (40)

1. Sickles GM, Mutterer M, Feorino P, Plager H. 1955. Recently classified types of coxsackie virus, group A; behavior in tissue culture. Proc Soc Exp Biol Med 90:529-531. http://dx.doi.org/10.3181/00379727-90-22088.
2. Bendig JW, Fleming DM. 1996. Epidemiological, virological, and clinical features of an epidemic of hand, foot, and mouth disease in England and Wales. Commun Dis Rep CDR Rev 6:R81-R86.
3. Chang LY. 2008. Enterovirus 71 in Taiwan. Pediatr Neonatol 49:103-112. http://dx.doi.org/10.1016/S1875-9572(08)60023-6.
4. Ang LW, Koh BK, Chan KP, Chua LT, James L, Goh KT. 2009. Epidemiology and control of hand, foot and mouth disease in Singapore, 2001-2007. Ann Acad Med Singapore 38:106-112.
5. Chang LY, Lin TY, Huang YC, Tsao KC, Shih SR, Kuo ML, Ning HC, Chung PW, Kang CM. 1999. Comparison of enterovirus 71 and coxsackie- virus A16 clinical illnesses during the Taiwan enterovirus epidemic, 1998. Pediatr Infect Dis J 18:1092-1096. http://dx.doi.org/10.1097 /00006454-199912000-00013.
6. Chen X, Tan X, Li J, Jin Y, Gong L, Hong M, Shi Y, Zhu S, Zhang B, Zhang S, Zhang Y, Mao N, Xu W. 2013. Molecular epidemiology of coxsackievirus A16: intratype and prevalent intertype recombination identified. PLoS One 8:e82861. http://dx.doi.org/10.1371/journal.pone .0082861.
7. Liu W, Wu S, Xiong Y, Li T, Wen Z, Yan M, Qin K, Liu Y, Wu J. 2014. Co-circulation and genomic recombination of coxsackievirus A16 and enterovirus 71 during a large outbreak of hand, foot, and mouth disease in central China. PLoS One 9:e96051. http://dx.doi.org/10.1371/journal .pone.0096051.
8. Wang CY, Li Lu F, Wu MH, Lee CY, Huang LM. 2004. Fatal coxsackievirus A16 infection. Pediatr Infect Dis J 23:275-276. http://dx.doi.org/10 .1097/01.inf.0000115950.63906.78.
9. Legay F, Leveque N, Gacouin A, Tattevin P, Bouet J, Thomas R, Chomelt JJ. 2007. Fatal coxsackievirus A-16 pneumonitis in adult. Emerg Infect Dis 13:1084-1086. http://dx.doi.org/10.3201/eid1307.070295.
10. Chang LY, Lin TY, Hsu KH, Huang YC, Lin KL, Hsueh C, Shih SR, Ning HC, Hwang MS, Wang HS, Lee CY. 1999. Clinical features and risk factors of pulmonary oedema after enterovirus-71-related hand, foot, and mouth disease. Lancet 354:1682-1686. http://dx.doi.org/10.1016/S0140 -6736(99)04434-7.
11. Chang LY, Huang LM, Gau SS, Wu YY, Hsia SH, Fan TY, Lin KL, Huang YC, Lu CY, Lin TY. 2007. Neurodevelopment and cognition in children after enterovirus 71 infection.NEngl JMed356:1226-1234. http: //dx.doi.org/10.1056/NEJMoa065954.
12. Chang LY, Tsao KC, Hsia SH, Shih SR, Huang CG, Chan WK, Hsu KH, Fang TY, Huang YC, Lin TY. 2004. Transmission and clinical features of enterovirus 71 infections in household contacts in Taiwan. JAMA 291: 222-227. http://dx.doi.org/10.1001/jama.291.2.222.
13. Ho M, Chen ER, Hsu KH, Twu SJ, Chen KT, Tsai SF, Wang JR, Shih SR. 1999. An epidemic of enterovirus 71 infection in Taiwan. Taiwan Enterovirus Epidemic Working Group. N Engl J Med 341:929-935.
14. Chehadeh W, Alkhabbaz M. 2013. Differential TLR7-mediated expression of proinflammatory and antiviral cytokines in response to laboratory and clinical enterovirus strains. Virus Res 174:88-94. http://dx.doi.org/10 .1016/j.virusres.2013.03.006.
15. Wang JP, Cerny A, Asher DR, Kurt-Jones EA, Bronson RT, Finberg RW. 2010. MDA5 and MAVS mediate type I interferon responses to coxsackie B virus. J Virol 84:254-260. http://dx.doi.org/10.1128/JVI.00631-09.
16. Oshiumi H, Okamoto M, Fujii K, Kawanishi T, Matsumoto M, Koike S, Seya T. 2011. The TLR3/TICAM-1 pathway is mandatory for innate immune responses to poliovirus infection. J Immunol 187:5320-5327. http://dx.doi.org/10.4049/jimmunol.1101503.
17. Lei X, Liu X, Ma Y, Sun Z, Yang Y, Jin Q, He B, Wang J. 2010. The 3C protein of enterovirus 71 inhibits retinoid acid-inducible gene I-mediated interferon regulatory factor 3 activation and type I interferon responses. J Virol 84:8051-8061. http://dx.doi.org/10.1128/JVI.02491-09.
18. Lei X, Sun Z, Liu X, Jin Q, He B, Wang J. 2011. Cleavage of the adaptor protein TRIF by enterovirus 71 3C inhibits antiviral responses mediated by Toll-like receptor 3. J Virol 85:8811-8818. http://dx.doi.org/10.1128 /JVI.00447-11.
19. Wang B, Xi X, Lei X, Zhang X, Cui S, Wang J, Jin Q, Zhao Z. 2013. Enterovirus 71 protease 2Apro targets MAVS to inhibit anti-viral type I interferon responses. PLoS Pathog 9:e1003231. http://dx.doi.org/10.1371 /journal.ppat.1003231.
20. Liu ML, Lee YP, Wang YF, Lei HY, Liu CC, Wang SM, Su IJ, Wang JR, Yeh TM, Chen SH, Yu CK. 2005. Type I interferons protect mice against enterovirus 71 infection. J Gen Virol 86:3263-3269. http://dx.doi.org/10 .1099/vir.0.81195-0.
21. Liao CC, Liou AT, Chang YS, Wu SY, Chang CS, Lee CK, Kung JT, Tu PH, Yu YY, Lin CY, Lin JS, Shih C. 2014. Immunodeficient mouse models with different disease profiles by in vivo infection with the same clinical isolate of enterovirus 71. J Virol 88:12485-12499. http://dx.doi.org /10.1128/JVI.00692-14.
22. Zhu K, Yang J, Luo K, Yang C, Zhang N, Xu R, Chen J, Jin M, Xu B, Guo N, Wang J, Chen Z, Cui Y, Zhao H, Wang Y, Deng C, Bai L, Ge B, Qin CF, Shen H, Yang CF, Leng Q. 2015. TLR3 signaling in macrophages is indispensable for the protective immunity of invariant natural killer T cells against enterovirus 71 infection. PLoS Pathog 11:e1004613. http://dx.doi.org/10.1371/journal.ppat.1004613.
23. Chan YF, AbuBaker S. 2004. Recombinant human enterovirus 71 in hand, foot and mouth disease patients. Emerg Infect Dis 10:1468-1470. http://dx.doi.org/10.3201/eid1008.040059.
24. Ministry of Science and Technology. 2006. Guide for the care and use of laboratory animals. Ministry of Science and Technology, Beijing, People's Republic of China. http://www.most.gov.cn/fggw/zfwj/zfwj2006/200609 /t20060930_54389.htm.
25. Zhao H, Li HY, Han JF, Deng YQ, Zhu SY, Li XF, Yang HQ, Li YX, Zhang Y, Qin ED, Chen R, Qin CF. 2015. Novel recombinant chimeric virus-like particle is immunogenic and protective against both enterovirus 71 and coxsackievirus A16 in mice. Sci Rep 5:7878. http://dx.doi.org/10 .1038/srep07878.
26. Weischenfeldt J, Porse B. 2008. Bone marrow-derived macrophages (BMM): isolation and applications. CSH Protocols 2008:pdb.prot5080. http://dx.doi.org/10.1101/pdb.prot5080.
27. Jozefczuk J, Drews K, Adjaye J. 2012. Preparation of mouse embryonic fibroblast cells suitable for culturing human embryonic and induced pluripotent stem cells. J Vis Exp 2012:3854. http://dx.doi.org/10.3791/3854.
28. Khong WX, Yan B, Yeo H, Tan EL, Lee JJ, Ng JK, Chow VT, Alonso S. 2012. A non-mouse-adapted enterovirus 71 (EV71) strain exhibits neurotropism causing neurological manifestations in a novel mouse model of EV71 infection. J Virol 86:2121-2131. http://dx.doi.org/10 .1128/JVI.06103-11.
29. Xing W, Liao Q, Viboud C, Zhang J, Sun J, Wu JT, Chang Z, Liu F, Fang VJ, Zheng Y, Cowling BJ, Varma JK, Farrar JJ, Leung GM, Yu H. 2014. Hand, foot, and mouth disease in China, 2008-12: an epidemiological study. Lancet Infect Dis 14:308-318. http://dx.doi.org/10.1016/S1473 -3099(13)70342-6.
30. Zhang W, Zhang L, Wu Z, Tien P. 2014. Differential interferon pathway gene expression patterns in rhabdomyosarcoma cells during enterovirus 71 or coxsackievirus A16 infection. Biochem Biophys Res Commun 447: 550-555. http://dx.doi.org/10.1016/j.bbrc.2014.04.021.
31. Chen CS, Yao YC, Lin SC, Lee YP, Wang YF, Wang JR, Liu CC, Lei HY, Yu CK. 2007. Retrograde axonal transport: a major transmission route of enterovirus 71 in mice. J Virol 81:8996-9003. http://dx.doi.org/10.1128 /JVI.00236-07.
32. Lin YW, Chang KC, Kao CM, Chang SP, Tung YY, Chen SH. 2009. Lymphocyte and antibody responses reduce enterovirus 71 lethality in mice by decreasing tissue viral loads. J Virol 83:6477-6483. http://dx.doi .org/10.1128/JVI.00434-09.
33. Wang YF, Chou CT, Lei HY, Liu CC, Wang SM, Yan JJ, Su IJ, Wang JR, Yeh TM, Chen SH, Yu CK. 2004. A mouse-adapted enterovirus 71 strain causes neurological disease in mice after oral infection. J Virol 78:7916- 7924. http://dx.doi.org/10.1128/JVI.78.15.7916-7924.2004.
34. Shi Y, He X, Zhu G, Tu H, Liu Z, Li W, Han S, Yin J, Peng B, Liu W. 2015. Coxsackievirus A16 elicits incomplete autophagy involving the mTOR and ERK pathways. PLoS One 10:e0122109. http://dx.doi.org/10 .1371/journal.pone.0122109.
35. Li Z, Yu J, Liu L, Wei Z, Ehrlich ES, Liu G, Li J, Liu X, Wang H, Yu XF, Zhang W. 2014. Coxsackievirus A16 infection induces neural cell and non-neural cell apoptosis in vitro. PLoS One 9:e111174. http://dx.doi.org /10.1371/journal.pone.0111174.
36. Brandenburg B, Lee LY, Lakadamyali M, Rust MJ, Zhuang X, Hogle JM. 2007. Imaging poliovirus entry in live cells. PLoS Biol 5:e183. http: //dx.doi.org/10.1371/journal.pbio.0050183.
37. Ren J, Wang X, Hu Z, Gao Q, Sun Y, Li X, Porta C, Walter TS, Gilbert RJ, Zhao Y, Axford D, Williams M, McAuley K, Rowlands DJ, Yin W, Wang J, Stuart DI, Rao Z, Fry EE. 2013. Picornavirus uncoating intermediate captured in atomic detail. Nat Commun 4:1929. http://dx.doi.org /10.1038/ncomms2889.
38. Matsumoto M, Funami K, Tanabe M, Oshiumi H, Shingai M, Seto Y, Yamamoto A, Seya T. 2003. Subcellular localization of Toll-like receptor 3 in human dendritic cells. J Immunol 171:3154-3162. http://dx.doi.org /10.4049/jimmunol.171.6.3154.
39. Loo YM, Gale M, Jr. 2011. Immune signaling by RIG-I-like receptors. Immunity 34:680-692. http://dx.doi.org/10.1016/j.immuni.2011.05.003.
40. Yen FB, Chang LY, Kao CL, Lee PI, Chen CM, Lee CY, Shao PL, Wang SC, Lu CY, Huang LM. 2009. Coxsackieviruses infection in northern Taiwan-epidemiology and clinical characteristics. J Microbiol Immunol Infect 42:38-46.